Safety and Efficacy of Turoctocog Alfa During Long-Term Treatment of Severe and Moderately Severe Haemophilia A



Status:Enrolling by invitation
Conditions:Hematology, Hematology
Therapuetic Areas:Hematology
Healthy:No
Age Range:Any
Updated:3/13/2019
Start Date:June 5, 2014
End Date:June 1, 2020

Use our guide to learn which trials are right for you!

A Multi-centre Non-interventional Study of Safety and Efficacy of Turoctocog Alfa (rFVIII) During Long-Term Treatment of Severe and Moderately Severe Haemophilia A (FVIII =<2%)

This study is conducted in Europe, and North and South America. The aim of this study is to
provide additional documentation of the immunogenicity, and obtain additional clinical data,
of turoctocog alfa in the setting of normal clinical practise in patients previously treated
with a factor VIII agent (FVIII).


Inclusion Criteria:

- Informed consent obtained before any study-related activities. Study-related
activities are any procedure related to recording of data according to the protocol

- Previously FVIII treated (150 exposure days at the time of first dosing with
turoctocog alfa) male patients with the diagnosis of severe and moderately severe
haemophilia A (FVIII below or equal to 2%)

- The decision to initiate treatment with commercially available turoctocog alfa has
been made by the patient/parent and the patient's treating physician before and
independently from the decision to include the patient in this study

- A negative FVIII inhibitor test obtained not more than four weeks prior to first
dosing with turoctocog alfa

Exclusion Criteria:

- Contraindications for use according to the approved product information text (US
Package insert (PI), European Summary of Product Characteristics (SmPC), or
corresponding local prescribing information)

- Treatment with any investigational drug within 30 days prior to enrolment into the
study

- Previous participation in any clinical trial with turoctocog alfa

- Treatment with other FVIII products after initiation of treatment with turoctocog alfa
We found this trial at
7
sites
Charlotte, North Carolina 28277
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
Albuquerque, New Mexico 87102
?
mi
from
Albuquerque, NM
Click here to add this to my saved trials
?
mi
from
Graz,
Click here to add this to my saved trials
Mobile, Alabama 36608
?
mi
from
Mobile, AL
Click here to add this to my saved trials
Peoria, Illinois 61615
?
mi
from
Peoria, IL
Click here to add this to my saved trials
Salt Lake City, Utah 84132
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Torrance, California 90502
?
mi
from
Torrance, CA
Click here to add this to my saved trials